Omnicell
Lisa Ritsky-Lamb joined Omnicell in November 2016, bringing over 25 years of financial experience in the healthcare industry. Ms. Ritsky-Lamb oversees all North America Commercial Finance and Financial Planning and Analysis activities. She is also responsible for Business Development financial analysis and SIOP (Sales, Inventory and Operations Planning) process management/financial analysis. Prior to joining Omnicell, Ms. Ritsky-Lamb provided financial business partnering support for the top Corporate Accounts at Thermo Fisher Scientific. She also spent over 13 years at Cardinal Health, growing her career through multiple Finance and Accounting roles. She received a BA in Theatre from Old Dominion University; a BS in Business Administration with an Accounting concentration from The University of Tennessee, Knoxville; and a Master’s Degree in Business Administration from Franklin University in Columbus, Ohio.
This person is not in any offices
Omnicell
26 followers
Since 1992, Omnicell (NASDAQ: OMCL) has been transforming the pharmacy care delivery model through the Autonomous Pharmacy, a combination of hardware, software, and services that enables providers to improve quality, reduce costs, and increase human efficiencies. Through Omnicell’s industry-leading medication management platform and portfolio of technology-enabled services, health systems and retail pharmacies are realizing how connected technology and intelligence can help solve for the most pressing challenges in medication management.